1 The primary outcome was 30-day mortality with Medicare reimbu
2 The primary outcome was a composite of long-term CV events or
3 The primary outcome was a composite of repeat ED visit, hospi
4 The primary outcome was a composite of systemic inflammatory
5 The primary outcome was a good neurologic outcome at 6 months
6 The primary outcome was a list of novel loci and their pathwa
7 The primary outcome was a relative reduction of 50% or more i
8 The primary outcome was all-cause mortality until 28 days.
9 The primary outcome was all-cause mortality.
10 The primary outcome was all-cause mortality; myocardial infar
11 The primary outcome was antibiotic administration in the firs
12 The primary outcome was best-corrected visual acuity (BCVA) a
13 The primary outcome was change from baseline to 36 months on
14 The primary outcome was change from baseline to 8 weeks in ac
15 The primary outcome was change in Functional Outcomes of Slee
16 The primary outcome was change in HbA1c from randomisation to
17 The primary outcome was change in HbA1c levels at 3 months.
18 The primary outcome was change in mean total TRS score at the
19 The primary outcome was detection of active or past placental
20 The primary outcome was effect at week 12 on the PANSS Total
21 The primary outcome was ESRD or 50% reduction in eGFR.
22 The primary outcome was hs-CRP level.
23 lysis to evaluate the clinical usefulness of each score and
the primary outcome was in-hospital mortality.
24 The primary outcome was incidence of bowel intervention, defi
25 The primary outcome was incidence of clinical malaria.
26 The primary outcome was inhospital mortality.
27 The primary outcome was maternal self-reported adherence to 4
28 The primary outcome was membership in high-symptom trajectori
29 The primary outcome was neonatal mortality.
30 The primary outcome was neurosensory impairment, defined as p
31 The primary outcome was noncalcified coronary artery plaque v
32 The primary outcome was not statistically lower with bleach (
33 The primary outcome was placebo-corrected 24-h systolic ambul
34 The primary outcome was progression-free-survival.
35 The primary outcome was reported using the modified Rankin Sc
36 The primary outcome was survival to discharge.
37 The primary outcome was the incidence of adverse events among
38 The primary outcome was the number of donations over 2 years.
39 The primary outcome was the number of laboratory-confirmed vi
40 The primary outcome was the proportion of duodenoscopes with
41 The primary outcome was the proportion of households in which
42 The primary outcome was the proportion of individuals who had
43 The primary outcome was the proportion of patients with an ad
44 The primary outcome was the rate of survival without BPD at 3
45 The primary outcome was the score on the modified Rankin scal
46 The primary outcome was the time to recovery of kidney functi
47 The primary outcome was to determine the changes in expressio
48 The primary outcome was treatment completion, defined as 11 o
49 The primary outcome was weight at 1 year of follow-up, analys
50 The primary outcome was weight change over 12 months, based o